Neurodegenerative disease market to reach $88.5 billion by 2030 at 9.0% cagr, driven by increase in research and clinical trials.
Read More
Microbial api market to reach $95.49 billion by 2030 at 7.0% CAGR, driven by rising prevalence of chronic conditions.
Read More
Netupitant-palonosetron fdc market to reach $608.99 billion by 2030 at 9.6% cagr, driven by increasing prevalence of cancer.
Read More
Mexiletine hydrochloride market to reach $1.93 billion by 2030 at 8.4% CAGR, driven by increasing number of cardiovascular diseases.
Read More
Nerve growth factor market to reach $1.71 billion by 2030 at 7.6% cagr, driven by increasing prevalence of neurological disorders.
Read More
Metronidazole market to reach $0.8 billion by 2030 at 5.5% CAGR, driven by increasing incidence of bacterial infections.
Read More
Methylsulfonylmethane (msm) supplements market to reach $2.07 billion by 2030 at 8.9% CAGR, driven by increase in prevalence of joint disorders and rise in aging population.
Read More
Nephrology drugs market to reach $24.32 billion by 2030 at 6.7% cagr, driven by rising prevalence of chronic kidney disease.
Read More
Neck pain treatment solutions market to reach $8.79 billion by 2030 at 6.0% cagr, driven by increasing sedentary lifestyles.
Read More
Nebivolol tablets market to reach $1.67 billion by 2030 at 6.5% cagr, driven by increasing prevalence of cardiovascular diseases and growing demand for generic drugs.
Read More